Front Page - Latvijas Organiskās sintēzes institūts

Menu

The leading drug discovery and development centre in the Baltics

Latvian Institute of Organic Synthesis (LIOS) receives €2.5 M ERA Chair grant from Horizon Europe Framework Programme

An attractive methodology for obtaining 1-aminoisoquinoline derivatives

LIOS researchers published voluminous review on acylcarnitines

Scientists discover synthetic approach toward enantiopure cyclic sulfinamides

Researchers at LIOS find a solution to currently unavailable fluorodiazomethane

How to become employer of choice in life science academia

Research

Services

Laboratories

Research in organic chemistry, pharmaceutical research, molecular biology and bioorganic chemistry

News

Latvian Institute of Organic Synthesis (LIOS) receives €2.5 M ERA Chair grant from Horizon Europe Framework Programme

03/11/2022

The aim of ERA Chair project “Natural Products Research at...

The 2nd Drug Discovery Conference – an event to make new collaborations and inspire innovative discoveries

03/10/2022

From September 22nd to 24th, the Latvian Institute of Organic...

An attractive methodology for obtaining 1-aminoisoquinoline derivatives

17/08/2022

Continuing studies of cobalt-catalyzed C–H bond functionalization reactions Liene Grigorjeva,...

LIOS researchers published voluminous review on acylcarnitines

01/07/2022

The review article by scientists from the Laboratory of Pharmaceutical...

Scientists discover synthetic approach toward enantiopure cyclic sulfinamides

21/06/2022

Prof. Edgars Suna’s group (Latvian Institute of Organic Synthesis) has...